View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsHongda Xingye 配当と自社株買い配当金 基準チェック /06Hongda Xingye現在配当金を支払っていません。主要情報0%配当利回り-3.7%バイバック利回り総株主利回り-3.7%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向0%最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Dec 30Hongda Xingye Co., Ltd. to Report Fiscal Year 2023 Results on Apr 29, 2024Hongda Xingye Co., Ltd. announced that they will report fiscal year 2023 results on Apr 29, 2024Reported Earnings • Nov 01Third quarter 2023 earnings released: CN¥0.11 loss per share (vs CN¥0.003 profit in 3Q 2022)Third quarter 2023 results: CN¥0.11 loss per share (down from CN¥0.003 profit in 3Q 2022). Revenue: CN¥270.7m (down 78% from 3Q 2022). Net loss: CN¥337.2m (down CN¥345.4m from profit in 3Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 52 percentage points per year, which is a significant difference in performance.お知らせ • Oct 19Hongda Xingye Co., Ltd.(XSEC:002002) dropped from S&P Global BMI IndexHongda Xingye Co., Ltd.(XSEC:002002) dropped from S&P Global BMI IndexNew Risk • Oct 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Earnings have declined by 17% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.0% average weekly change).Reported Earnings • Aug 31Second quarter 2023 earnings released: CN¥0.16 loss per share (vs CN¥0.057 profit in 2Q 2022)Second quarter 2023 results: CN¥0.16 loss per share (down from CN¥0.057 profit in 2Q 2022). Revenue: CN¥1.11b (down 33% from 2Q 2022). Net loss: CN¥478.4m (down 371% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.Board Change • Aug 04Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Ruihao Liao was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Jun 13Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Ruihao Liao was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • May 06Hongda Xingye Co., Ltd., Annual General Meeting, May 22, 2023Hongda Xingye Co., Ltd., Annual General Meeting, May 22, 2023, at 15:00 China Standard Time. Agenda: To consider 2022 annual report and its summary; to consider 2022 work report of the board of directors; to consider 2022 work report of the supervisory committee; to consider 2022 annual accounts; to consider 2022 profit distribution plan; to consider Confirmation of 2022 continuing connected transactions of the Company and its subsidiaries and 2023 estimated continuing connected transactions; to consider 2022 special report on the deposit and use of raised funds; and to consider other matters.Reported Earnings • Apr 30First quarter 2023 earnings released: EPS: CN¥0.001 (vs CN¥0.033 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.001 (down from CN¥0.033 in 1Q 2022). Revenue: CN¥834.2m (down 8.3% from 1Q 2022). Net income: CN¥1.96m (down 98% from 1Q 2022). Profit margin: 0.2% (down from 11% in 1Q 2022). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.Reported Earnings • Oct 31Third quarter 2022 earnings released: EPS: CN¥0.003 (vs CN¥0.21 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.003 (down from CN¥0.21 in 3Q 2021). Revenue: CN¥1.25b (down 42% from 3Q 2021). Net income: CN¥8.24m (down 99% from 3Q 2021). Profit margin: 0.7% (down from 25% in 3Q 2021). Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 7% per year.Reported Earnings • Sep 03Second quarter 2022 earnings released: EPS: CN¥0.057 (vs CN¥0.16 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.057 (down from CN¥0.16 in 2Q 2021). Revenue: CN¥1.67b (down 11% from 2Q 2021). Net income: CN¥176.4m (down 66% from 2Q 2021). Profit margin: 11% (down from 28% in 2Q 2021). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥4.31, the stock trades at a trailing P/E ratio of 19.5x. Average trailing P/E is 29x in the Chemicals industry in China. Total loss to shareholders of 2.6% over the past three years.Reported Earnings • May 02First quarter 2022 earnings released: EPS: CN¥0.033 (vs CN¥0.099 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.033 (down from CN¥0.099 in 1Q 2021). Revenue: CN¥909.4m (down 45% from 1Q 2021). Net income: CN¥102.5m (down 62% from 1Q 2021). Profit margin: 11% (down from 16% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 5 independent directors (6 non-independent directors). Independent Director Ruihao Liao was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Apr 20Full year 2021 earnings released: EPS: CN¥0.33 (vs CN¥0.31 in FY 2020)Full year 2021 results: EPS: CN¥0.33 (up from CN¥0.31 in FY 2020). Revenue: CN¥6.52b (up 21% from FY 2020). Net income: CN¥851.8m (up 4.7% from FY 2020). Profit margin: 13% (down from 15% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings.Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.098 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥2.14b (up 63% from 3Q 2020). Net income: CN¥538.4m (up 114% from 3Q 2020). Profit margin: 25% (up from 19% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Sep 30Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to CN¥5.49, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 70% over the past three years.Valuation Update With 7 Day Price Move • Sep 01Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥6.45, the stock trades at a trailing P/E ratio of 14.2x. Average trailing P/E is 32x in the Chemicals industry in China. Total returns to shareholders of 122% over the past three years.Reported Earnings • Aug 19Second quarter 2021 earnings released: EPS CN¥0.16 (vs CN¥0.055 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.89b (up 60% from 2Q 2020). Net income: CN¥521.9m (up 270% from 2Q 2020). Profit margin: 28% (up from 12% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Jul 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥4.94, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 37% over the past three years.Reported Earnings • May 01First quarter 2021 earnings released: EPS CN¥0.099 (vs CN¥0.074 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥1.64b (up 14% from 1Q 2020). Net income: CN¥269.4m (up 41% from 1Q 2020). Profit margin: 16% (up from 13% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings.Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥4.13, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 35x in the Chemicals industry in China. Total loss to shareholders of 32% over the past three years.Reported Earnings • Apr 04Full year 2020 earnings released: EPS CN¥0.31 (vs CN¥0.24 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥5.39b (up 1.8% from FY 2019). Net income: CN¥813.8m (up 29% from FY 2019). Profit margin: 15% (up from 12% in FY 2019). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 18% per year.Valuation Update With 7 Day Price Move • Feb 23Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥3.72, the stock is trading at a trailing P/E ratio of 13.2x, up from the previous P/E ratio of 11.2x. This compares to an average P/E of 37x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 43%.Is New 90 Day High Low • Dec 30New 90-day low: CN¥2.95The company is down 22% from its price of CN¥3.80 on 30 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.Valuation Update With 7 Day Price Move • Dec 18Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥3.18, the stock is trading at a trailing P/E ratio of 11.3x, down from the previous P/E ratio of 13.3x. This compares to an average P/E of 36x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 52%.Valuation Update With 7 Day Price Move • Dec 16Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to CN¥3.09, the stock is trading at a trailing P/E ratio of 10.9x, down from the previous P/E ratio of 13.5x. This compares to an average P/E of 37x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 53%.Is New 90 Day High Low • Dec 15New 90-day low: CN¥3.42The company is down 19% from its price of CN¥4.24 on 17 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period.Is New 90 Day High Low • Nov 25New 90-day high: CN¥4.28The company is up 9.0% from its price of CN¥3.92 on 27 August 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 11% over the same period.Is New 90 Day High Low • Oct 30New 90-day low: CN¥3.60The company is down 8.0% from its price of CN¥3.92 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period.Reported Earnings • Oct 29Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥726.8m, up 67% from the prior year. Total revenue was CN¥5.17b over the last 12 months, down 10% from the prior year.決済の安定と成長配当データの取得安定した配当: 002002の 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: 002002の配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Hongda Xingye 配当利回り対市場002002 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (002002)0%市場下位25% (CN)0.4%市場トップ25% (CN)2.3%業界平均 (Chemicals)1.4%アナリスト予想 (002002) (最長3年)n/a注目すべき配当: 002002は最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: 002002は最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: 002002 CN市場において目立った配当金を支払っていません。株主配当金キャッシュフローカバレッジ: 002002が配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YCN 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/03/20 09:37終値2024/01/18 00:00収益2023/09/30年間収益2022/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Hongda Xingye Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Xiaofeng QiuEverbright Securities Co. Ltd.Xi LiuHuatai Research
お知らせ • Dec 30Hongda Xingye Co., Ltd. to Report Fiscal Year 2023 Results on Apr 29, 2024Hongda Xingye Co., Ltd. announced that they will report fiscal year 2023 results on Apr 29, 2024
Reported Earnings • Nov 01Third quarter 2023 earnings released: CN¥0.11 loss per share (vs CN¥0.003 profit in 3Q 2022)Third quarter 2023 results: CN¥0.11 loss per share (down from CN¥0.003 profit in 3Q 2022). Revenue: CN¥270.7m (down 78% from 3Q 2022). Net loss: CN¥337.2m (down CN¥345.4m from profit in 3Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 52 percentage points per year, which is a significant difference in performance.
お知らせ • Oct 19Hongda Xingye Co., Ltd.(XSEC:002002) dropped from S&P Global BMI IndexHongda Xingye Co., Ltd.(XSEC:002002) dropped from S&P Global BMI Index
New Risk • Oct 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Earnings have declined by 17% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.0% average weekly change).
Reported Earnings • Aug 31Second quarter 2023 earnings released: CN¥0.16 loss per share (vs CN¥0.057 profit in 2Q 2022)Second quarter 2023 results: CN¥0.16 loss per share (down from CN¥0.057 profit in 2Q 2022). Revenue: CN¥1.11b (down 33% from 2Q 2022). Net loss: CN¥478.4m (down 371% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.
Board Change • Aug 04Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Ruihao Liao was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Jun 13Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Ruihao Liao was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • May 06Hongda Xingye Co., Ltd., Annual General Meeting, May 22, 2023Hongda Xingye Co., Ltd., Annual General Meeting, May 22, 2023, at 15:00 China Standard Time. Agenda: To consider 2022 annual report and its summary; to consider 2022 work report of the board of directors; to consider 2022 work report of the supervisory committee; to consider 2022 annual accounts; to consider 2022 profit distribution plan; to consider Confirmation of 2022 continuing connected transactions of the Company and its subsidiaries and 2023 estimated continuing connected transactions; to consider 2022 special report on the deposit and use of raised funds; and to consider other matters.
Reported Earnings • Apr 30First quarter 2023 earnings released: EPS: CN¥0.001 (vs CN¥0.033 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.001 (down from CN¥0.033 in 1Q 2022). Revenue: CN¥834.2m (down 8.3% from 1Q 2022). Net income: CN¥1.96m (down 98% from 1Q 2022). Profit margin: 0.2% (down from 11% in 1Q 2022). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
Reported Earnings • Oct 31Third quarter 2022 earnings released: EPS: CN¥0.003 (vs CN¥0.21 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.003 (down from CN¥0.21 in 3Q 2021). Revenue: CN¥1.25b (down 42% from 3Q 2021). Net income: CN¥8.24m (down 99% from 3Q 2021). Profit margin: 0.7% (down from 25% in 3Q 2021). Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 7% per year.
Reported Earnings • Sep 03Second quarter 2022 earnings released: EPS: CN¥0.057 (vs CN¥0.16 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.057 (down from CN¥0.16 in 2Q 2021). Revenue: CN¥1.67b (down 11% from 2Q 2021). Net income: CN¥176.4m (down 66% from 2Q 2021). Profit margin: 11% (down from 28% in 2Q 2021). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥4.31, the stock trades at a trailing P/E ratio of 19.5x. Average trailing P/E is 29x in the Chemicals industry in China. Total loss to shareholders of 2.6% over the past three years.
Reported Earnings • May 02First quarter 2022 earnings released: EPS: CN¥0.033 (vs CN¥0.099 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.033 (down from CN¥0.099 in 1Q 2021). Revenue: CN¥909.4m (down 45% from 1Q 2021). Net income: CN¥102.5m (down 62% from 1Q 2021). Profit margin: 11% (down from 16% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 5 independent directors (6 non-independent directors). Independent Director Ruihao Liao was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Apr 20Full year 2021 earnings released: EPS: CN¥0.33 (vs CN¥0.31 in FY 2020)Full year 2021 results: EPS: CN¥0.33 (up from CN¥0.31 in FY 2020). Revenue: CN¥6.52b (up 21% from FY 2020). Net income: CN¥851.8m (up 4.7% from FY 2020). Profit margin: 13% (down from 15% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings.
Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.098 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥2.14b (up 63% from 3Q 2020). Net income: CN¥538.4m (up 114% from 3Q 2020). Profit margin: 25% (up from 19% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to CN¥5.49, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 70% over the past three years.
Valuation Update With 7 Day Price Move • Sep 01Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥6.45, the stock trades at a trailing P/E ratio of 14.2x. Average trailing P/E is 32x in the Chemicals industry in China. Total returns to shareholders of 122% over the past three years.
Reported Earnings • Aug 19Second quarter 2021 earnings released: EPS CN¥0.16 (vs CN¥0.055 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.89b (up 60% from 2Q 2020). Net income: CN¥521.9m (up 270% from 2Q 2020). Profit margin: 28% (up from 12% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Jul 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥4.94, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 37% over the past three years.
Reported Earnings • May 01First quarter 2021 earnings released: EPS CN¥0.099 (vs CN¥0.074 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥1.64b (up 14% from 1Q 2020). Net income: CN¥269.4m (up 41% from 1Q 2020). Profit margin: 16% (up from 13% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings.
Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥4.13, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 35x in the Chemicals industry in China. Total loss to shareholders of 32% over the past three years.
Reported Earnings • Apr 04Full year 2020 earnings released: EPS CN¥0.31 (vs CN¥0.24 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥5.39b (up 1.8% from FY 2019). Net income: CN¥813.8m (up 29% from FY 2019). Profit margin: 15% (up from 12% in FY 2019). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 18% per year.
Valuation Update With 7 Day Price Move • Feb 23Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥3.72, the stock is trading at a trailing P/E ratio of 13.2x, up from the previous P/E ratio of 11.2x. This compares to an average P/E of 37x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 43%.
Is New 90 Day High Low • Dec 30New 90-day low: CN¥2.95The company is down 22% from its price of CN¥3.80 on 30 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.
Valuation Update With 7 Day Price Move • Dec 18Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥3.18, the stock is trading at a trailing P/E ratio of 11.3x, down from the previous P/E ratio of 13.3x. This compares to an average P/E of 36x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 52%.
Valuation Update With 7 Day Price Move • Dec 16Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to CN¥3.09, the stock is trading at a trailing P/E ratio of 10.9x, down from the previous P/E ratio of 13.5x. This compares to an average P/E of 37x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 53%.
Is New 90 Day High Low • Dec 15New 90-day low: CN¥3.42The company is down 19% from its price of CN¥4.24 on 17 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period.
Is New 90 Day High Low • Nov 25New 90-day high: CN¥4.28The company is up 9.0% from its price of CN¥3.92 on 27 August 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 11% over the same period.
Is New 90 Day High Low • Oct 30New 90-day low: CN¥3.60The company is down 8.0% from its price of CN¥3.92 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period.
Reported Earnings • Oct 29Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥726.8m, up 67% from the prior year. Total revenue was CN¥5.17b over the last 12 months, down 10% from the prior year.